Advertisement

Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x100px
Document › Details

Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg.

Region Region EU (European Union)
Organisations Organisation Pentixapharm Holding AG (FSE Prime Standard: PTP)
  Today Pentixapharm (Group)
  Group Pentixapharm (Group)
  Organisation 2 EMA (European Medicines Agency)
  Group EU (govt)
Products Product PentixaFor (gallium-68-based companion diagnostic)
  Product 2 positron emission tomography (PET)
Persons Person Riehle, Karolin (Eckert & Ziegler 202212 Investor Relations + PR)
  Person 2 Hennecke, Anne (MC Services 201211 Managing Partner before Evotec + Schwarz Pharma)
     


[Not for US, AU, CA, JP, ZA, et al.]

   
Record changed: 2024-09-29

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

More documents for Pentixapharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x300px




» top